KEGG   DRUG: Cysteamine hydrochloride
Entry
D03635                      Drug                                   
Name
Cysteamine hydrochloride (JAN/USAN);
Mercaptamine hydrochloride;
Cystaran (TN);
Cystadrops (TN)
Product
CYSTADROPS (RECORDATI RARE DISEASES), CYSTARAN (Leadiant Biosciences)
Formula
C2H7NS. HCl
Exact mass
113.0066
Mol weight
113.6096
Structure
Simcomp
Remark
Therapeutic category: 1319
ATC code: S01XA21
Chemical structure group: DG02658
Product (DG02658): D03635<JP/US> D10468<JP/US>
Efficacy
Anti-urolithic (cysteine calculi), Cystinosis treatment
  Disease
Cystinosis [DS:H00275]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 S SENSORY ORGANS
  S01 OPHTHALMOLOGICALS
   S01X OTHER OPHTHALMOLOGICALS
    S01XA Other ophthalmologicals
     S01XA21 Mercaptamine
      D03635  Cysteamine hydrochloride (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
 Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
  Cysteamine
   D03635  Cysteamine hydrochloride (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  13  Agents affecting sensory organs
   131  Ophthalmic agents
    1319  Others
     D03635  Cysteamine hydrochloride (JAN/USAN)
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D03635
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D03635
Other DBs
CAS: 156-57-0
PubChem: 17397739
LigandBox: D03635
NIKKAJI: J257.036J
LinkDB
KCF data

ATOM        5
            1   C1b C    22.5846  -15.8889
            2   C1b C    21.3750  -15.1909
            3   N1a N    23.8002  -15.1909
            4   S1a S    20.1594  -15.8889
            5   X   Cl   27.5800  -15.7500
BOND        3
            1     1   2 1
            2     1   3 1
            3     2   4 1

» Japanese version   » Back

DBGET integrated database retrieval system